ModGraProDep: Artificial intelligence and probabilistic modelling in clinical oncology

June 11, 2020

Improving the prediction of survival indicators in patients with breast cancer using tools from artificial intelligence and probabilistic modelling is the aim of ModGraProDep, an innovative system presented in a study led by Ramon Clèries, lecturer at the Department of Clinical Sciences of the Faculty of Medicine and Health Sciences of the University of Barcelona and member of the Oncology Master Plan/ICO-IDIBELL. The study has been published in the journal Artificial Intelligence in Medicine.

The new technology has been carried out by a team of experts on epidemiology, oncology and data management of the Oncology Master Plan - IDIBELL, the University of Barcelona, the Technical University of Catalonia, the Catalan Institute of Oncology (ICO), the Girona Biomedical Research Institute (IDIBGI), the University of Girona, the University of Alicante, the Epidemiology and Public Health Networking Biomedical Research Centre (CIBERESP), Carlos III Health Institute, the University Hospital Sant Joan de Reus, the Medical Oncology Service of ICO Girona, the Cancer Registry of Girona and Tarragona and the entity MC Mutual.

Mathematic modelling: new frontiers in the fight against cancer

One of the applications of numeric modelling for clinical indicators on oncology is the creation of predictive models to help oncologists and doctors to classify and value future scenarios of evolution in the patients with cancer. In this context, the prediction of survival in patients -with specific variables and ages- is a decisive element to consider treatments and identify subgroups among the patients. However, this information is sometimes estimated through numeric modelling since there is not enough sample population to calculate these indicators specifically.

The application of the new ModGraProDep Technology (Modelinng Graphical Probabilistic Dependencies) has led to two studies coordinated by the lecturer Mireia Vilardell, from the Section of Statistics at the Department of Genetics, Microbiology and Statistics of the Faculty of Biology of the UB, and the researcher Maria Buxó, from IDIBGI.

In the first case, ModGraProDep enables users to identify the structure of the database and to create a "synthetic" population of patients with the demographical features of the original cohort. With this new approach, they can identify potential patterns of patients and calculate indicators (for instance, the survival of a patient depending on the values of his or her variables). In a second study, ModGraProDep reveals itself as a new technology which can allocate values in a probabilistic manner in variables for which there was no information gathered yet.

The scientific team has designed a web application of great clinic interest in the field of oncology that enables having a prediction of indicators on survival and risk of cancer mortality -and other causes- of each patient for a maximum period of twenty years.
-end-


University of Barcelona

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.